Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,716 | 128 | 90.3% |
| Travel and Lodging | $265.53 | 1 | 8.8% |
| Education | $26.22 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $639.29 | 28 | $0 (2020) |
| ModernaTX, Inc. | $571.53 | 6 | $0 (2024) |
| Amgen Inc. | $422.28 | 24 | $0 (2023) |
| Merz North America, Inc. | $198.00 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $197.01 | 10 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $183.71 | 12 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $162.02 | 15 | $0 (2020) |
| ARBOR PHARMACEUTICALS, INC. | $144.10 | 12 | $0 (2018) |
| Inspire Medical Systems, Inc. | $122.69 | 1 | $0 (2024) |
| Allergan, Inc. | $95.30 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $733.04 | 9 | ModernaTX, Inc. ($571.53) |
| 2023 | $72.59 | 4 | AstraZeneca Pharmaceuticals LP ($33.07) |
| 2021 | $52.78 | 3 | Dynavax Technologies Corporation ($21.31) |
| 2020 | $149.33 | 8 | Novo Nordisk Inc ($36.16) |
| 2019 | $411.27 | 24 | Amgen Inc. ($125.89) |
| 2018 | $622.50 | 26 | Merz North America, Inc. ($198.00) |
| 2017 | $966.60 | 57 | Novo Nordisk Inc ($350.36) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $122.69 | General |
| Category: NEUROLOGY | ||||||
| 09/14/2024 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $265.53 | General |
| 09/14/2024 | ModernaTX, Inc. | — | Food and Beverage | In-kind items and services | $120.00 | General |
| 09/14/2024 | ModernaTX, Inc. | — | Food and Beverage | In-kind items and services | $81.00 | General |
| 09/14/2024 | ModernaTX, Inc. | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 09/14/2024 | ModernaTX, Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 09/14/2024 | ModernaTX, Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 02/13/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Allergy/Immunology | ||||||
| 01/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Respiratory | ||||||
| 10/11/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Respiratory | ||||||
| 08/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/12/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Bone Health | ||||||
| 03/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: DIABETES | ||||||
| 08/04/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Bone Health | ||||||
| 07/27/2021 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Hepatitis B Vaccine | ||||||
| 07/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: DIABETES | ||||||
| 03/12/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/11/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Diabetes | ||||||
| 02/27/2020 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Education | In-kind items and services | $19.27 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 02/26/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Diabetes | ||||||
| 02/12/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Diabetes | ||||||
| 01/22/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: DIABETES | ||||||
| 01/15/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Bone Health | ||||||
| 11/14/2019 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $15.52 | General |
| Category: Allergy/Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,261 | 5,909 | $993,685 | $262,597 |
| 2022 | 32 | 2,625 | 4,430 | $971,593 | $272,055 |
| 2021 | 20 | 1,494 | 2,069 | $554,799 | $188,473 |
| 2020 | 25 | 1,356 | 2,708 | $332,601 | $166,844 |
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 2 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 22 | 24 | $7,296 | $1,607 | 22.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 22 | 22 | $5,720 | $1,339 | 23.4% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 17 | 33 | $3,960 | $1,126 | 28.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 31 | $2,263 | $1,074 | 47.4% |
| 94681 | Test to measure exhaled air and carbon dioxide for evaluation of lung function | Office | 2023 | 22 | 22 | $3,322 | $930.93 | 28.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 28 | 35 | $3,290 | $742.53 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,366 | $503.80 | 15.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 35 | 35 | $2,345 | $455.71 | 19.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 26 | 26 | $1,534 | $360.38 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 240 | 573 | $232,065 | $62,197 | 26.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 194 | 194 | $69,156 | $28,640 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 355 | $107,920 | $25,378 | 23.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 91 | 507 | $74,529 | $22,693 | 30.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 225 | 225 | $53,775 | $18,811 | 35.0% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 140 | 140 | $85,540 | $16,399 | 19.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 74 | 362 | $69,866 | $13,182 | 18.9% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2022 | 140 | 140 | $36,120 | $11,524 | 31.9% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 105 | 137 | $35,081 | $9,922 | 28.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 63 | 253 | $30,360 | $9,204 | 30.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 33 | 35 | $21,916 | $7,278 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 135 | $27,810 | $6,458 | 23.2% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2022 | 38 | 38 | $15,770 | $4,688 | 29.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 196 | 196 | $9,996 | $4,244 | 42.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 36 | 50 | $15,200 | $4,186 | 27.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 51 | 52 | $8,476 | $3,482 | 41.1% |
About Dr. Husna Baksh, M.D
Dr. Husna Baksh, M.D is a Family Medicine healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740396092.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Husna Baksh, M.D has received a total of $3,008 in payments from pharmaceutical and medical device companies, with $733.04 received in 2024. These payments were reported across 131 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,716).
As a Medicare-enrolled provider, Baksh has provided services to 7,736 Medicare beneficiaries, totaling 15,116 services with total Medicare billing of $889,968. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Internal Medicine
- Location Silver Spring, MD
- Active Since 08/21/2006
- Last Updated 04/26/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740396092
Products in Payments
- Victoza (Drug) $247.76
- Prolia (Biological) $226.52
- Tresiba (Drug) $212.42
- XEOMIN (Biological) $198.00
- Ozempic (Drug) $154.19
- FARXIGA (Drug) $130.00
- Aimovig (Biological) $125.89
- INSPIRE (Device) $122.69
- JANUVIA (Drug) $118.35
- TRADJENTA (Drug) $103.45
- JARDIANCE (Drug) $93.56
- Edarbi (Drug) $54.63
- EVENITY (Biological) $51.18
- ImmunoCAP (Device) $47.95
- LINZESS (Drug) $40.72
- HUMALOG (Drug) $37.74
- VIBERZI (Drug) $34.35
- Otovel (Drug) $31.78
- ASMANEX (Drug) $27.67
- Saxenda (Drug) $24.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Silver Spring
Dr. Jean Welsh, Md, MD
Family Medicine — Payments: $29,783
Adolph Johnson, M.d, M.D
Family Medicine — Payments: $13,149
Dr. Mark Major, M.d, M.D
Family Medicine — Payments: $9,878
Dr. Carlos Covarrubias Ponce, Md, MD
Family Medicine — Payments: $7,717
Mrs. Shelley Williams, M.d, M.D
Family Medicine — Payments: $7,163
Dr. Wendy Wong, M.d, M.D
Family Medicine — Payments: $5,757